Clinical Studies

Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
NeuroOphthalmology
Obesity/Weight Management
Women's Health
Other


Special Features
Advances/Research

 

Administration of Vitamin D Analog to New Onset Type1 Diabetes
Mellitus Patients to Restore Pancreatic Cell Function


Principal Investigator:   Agustin Busta, MD
Time frame of study:   1 year
Time frame of participation:   12 months
Number of participants needed:   Open
Location of Study:   Fierman Hall
317E. 17TH St. 7th Floor
New York, NY 10003
Contact Co-investigator  

Bianca Alfonso, MD
(212) 420-2054
balfonso@chpnet.org

Summary:

Subjects will be recruited from Mount Sinai Beth Israel – Emergency Department and Medical Wards, from Endocrinology Faculty Practice and General Medicine Clinic; we will advertise our study on Mount Sinai Beth Israel’s website.
The study will include 80 adults, males and females, with newly diagnosed type1 diabetes (time from diagnosis < 4weeks)
Subjects will be positive for at least one autoantibody to either glutamic acid decarboxylase or islet cell.